Aptamers as molecular probes in tumor molecular imaging

Abstract

Shi Yusheng, Peng Yonghua, Sheng Shuyue, Zhang Xingmei. Aptamers as molecular probes in tumor molecular imaging[J]. Journal of International Oncology, 2016, 43(11): 838-840.

［1］申宝忠. 无限潜能魅力彰显——分子影像学研究的回顾和展望［J］. 中华放射学杂志, 2014, 48(5): 353-357. ［2］ Hong H, Goel S, Zhang Y, et al. Molecular imaging with nucleic acid aptamers［J］. Curr Med Chem, 2011, 18(27): 4195-4205. ［3］ Rozenblum GT, Lopez VG, Vitullo AD, et al. Aptamers: current challenges and future prospects［J］. Expert Opin Drug Discov, 2015, 18: 1-9. DOI: 10.1517/17460441.2016.1126244. ［4］ Hernandez LI, Machado I, Schafer T, et al. Aptamers overview: selection, features and applications［J］. Curr Top Med Chem, 2015, 15(12): 1066-1081. ［5］ Wang AZ, Farokhzad OC. Current progress of aptamerbased molecular imaging［J］. J Nucl Med, 2014, 55(3): 353-356. DOI: 10.2967/jnumed.113.126144. ［6］ Hicke BJ, Stephens AW, Gould T, et al. Tumor targeting by an aptamer［J］. J Nucl Med, 2006, 47(4): 668-678. ［7］ Wu X, Liang H, Tan Y, et al. CellSELEX apt6amer for highly specific radionuclide molecular imaging of glioblastoma in vivo［J］. PLoS One, 2014, 9(6): e90752. DOI: 10.1371/journal.pone.0090752. ［8］ Jacobson O, Yan X, Niu G, et al. PET imaging of tenascinC with a radiolabeled singlestranded DNA aptamer［J］. J Nucl Med, 2015, 56(4): 616-621. DOI: 10.2967/jnumed.114.149484. ［9］ Li J, Zheng H, Bates PJ, et al. Aptamer imaging with Cu64 labeled AS1411: preliminary assessment in lung cancer［J］. Nucl Med Biol, 2014, 41(2): 179-185. DOI: 10.1016/j.nucmedbio.2013.10.008. ［10］ Chen T, Shukoor MI, Wang R, et al. Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging［J］. ACS Nano, 2011, 5(10): 7866-7873. DOI: 10.1021/nn202073m. ［11］ Wang AZ, Bagalkot V, Vasilliou CC, et al. Superparamagnetic iron oxide nanoparticleaptamer bioconjugates for combined prostate cancer imaging and therapy［J］. Chem Med Chem, 2008, 3(9): 13111315. DOI: 10.1002/cmdc.200800091. ［12］ Wang CH, Kang ST, Lee YH, et al. Aptamerconjugated and drugloaded acoustic droplets for ultrasound theranosis［J］. Biomaterials, 2012, 33(6): 1939-1947. DOI: 10.1016/j.biomaterials.2011.11.036. ［13］ Tong R, Coyle VJ, Tang L, et al. Polylactide nanoparticles containing stably incorporated cyanine dyes for in vitro and in vivo imaging applications［J］. Microsc Res Tech, 2010, 73(9): 901-909. DOI: 10.1002/jemt.20824. ［14］ Mi J, Zhang X, Giangrande PH, et al. Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival［J］. Biochem Biophys Res Commun, 2005, 338(2): 956-963. ［15］ Alibolandi M, Abnous K, Ramezani M, et al. Synthesis of AS1411aptamerconjugated CdTe quantum dots with high fluorescence strength for probe labeling tumor cells［J］. J Fluoresc, 2014, 24(5): 1519-1529. DOI : 10.1007/s10895-014-1437-5. ［16］ Kim Y, Wu Q, Hamerlik P, et al. Aptamer identification of brain tumorinitiating cells［J］. Cancer Res, 2013, 73(15): 4923-4936. DOI: 10.1158/0008-5472.CAN-12-4556. ［17］ Martínez O, Bellard E, Golzio M, et al. Direct validation of aptamers as powerful tools to image solid tumor［J］. Nucleic Acid Ther, 2014, 24(3): 217-225. DOI: 10.1089/nat.2013.0444. ［18］ Shi H, He X, Wang K, et al. Activatable aptamer probe for contrastenhanced in vivo cancer imaging based on cell membrane proteintriggered conformation alteration［J］. Proc Natl Acad Sci USA, 2011, 108(10): 3900-3905. DOI: 10.1073/pnas.1016197108. ［19］ Li L, Tong R, Chu H, et al. Aptamer photoregulation in vivo［J］. Proc Natl Acad Sci USA, 2014, 111(48): 17099-17103. DOI: 10.1073/pnas.1420105111.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Aptamers as molecular probes in tumor molecular imaging

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments